Delivery Order SPE2DB25D3005-SPE2DB25FQJSA
- Not listed
- The Defense Logistics Agency awarded a $14,582.36 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This is a firm fixed-price, non-set-aside contract with a completion date of July 31, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Descovy is an antiretroviral medication used in HIV prevention and treatment, and this delivery order represents a routine...
- The Defense Logistics Agency awarded a delivery order valued at $4,739.71 to AmerisourceBergen Drug Corp for Descovy 200-25 mg tablets (30-count units) on August 12, 2025, with an ultimate completion date of August 13, 2025. This competitive award, issued under firm fixed pricing with no set-aside designation, represents a pharmaceutical supply delivery from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania to the same location. Descovy is an antiretroviral medication used in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,772.57 to AmerisourceBergen Drug Corp for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This non-set-aside, firm fixed price delivery order was awarded on August 1, 2025, with an ultimate completion date of August 4, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Descovy is an antiretroviral medication used in HIV prevention and treatment, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $22,830.75 to AmerisourceBergen Drug Corp for 30-unit supplies of Descovy 200-25 mg tablets. This firm fixed-price, non-set-aside contract was executed on August 19, 2025, with an ultimate completion date of August 20, 2025, and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Descovy is an antiretroviral medication used in HIV prevention and treatment, reflecting the federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $2,658.42 to supply Descovy 200-25 mg tablets in quantities of 30, with performance in Conshohocken, Pennsylvania. The award, issued on August 18, 2025, represents a competitively awarded, firm fixed-price delivery order with no set-aside designation and an ultimate completion date of August 19, 2025. This delivery order is executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $28,993.50 to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This is a firm fixed price contract with an ultimate completion date of September 10, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the contractor's demonstrated...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $23,354.50 and an ultimate completion date of September 12, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. Performance will be executed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $13,660.97 to AmerisourceBergen Drug Corp for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order was issued on August 5, 2025, with an ultimate completion date of August 6, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30, with a contract ceiling value of $28,667.28. This is a firm fixed-price delivery order with an ultimate completion date of August 14, 2025, and represents a non-competitive set-aside award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $41,728.46 to AmerisourceBergen Drug Corp for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed price delivery order is scheduled for completion by August 20, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the contractor's demonstrated capability to compete in...
- SPE2DB25D3005Indefinite Delivery Contract
- SPE2DB25D3005-SPE2DB25FQJSADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $14,102.37 to AmerisourceBergen Drug Corp for Descovy 200-25 mg tablets (30-count units) on September 12, 2025, with an ultimate completion date of September 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Descovy is an antiretroviral medication used for HIV treatment and prevention, reflecting the Defense Logistics Agency's ongoing procurement of pharmaceutical products to support military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp supplies a comprehensive range of medications and medical supplies to federal customers including the Defense Health Agency and U.S. Coast Guard. The company's contract portfolio demonstrates consistent success in competitive federal procurement, with delivery orders spanning therapeutic domains from specialty medications to vaccines and medical devices, positioning it as a critical vendor within the federal medical supply chain.